Stroke and Atrial Fibrillation
| GEHC-SHSCA-DRSE-SAF-UN9012 | |
| Clinical Training | |
| GE HealthCare | |
Add to Wish List
Login To Shop
Please select date
Second Opinion Approval Needed
Enter your approval number and submit to add item(s) to cart.
Approval Number
Please enter approval number
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without the
approval number, GE will contact you before your order
can be confirmed for shipment.
Second Opinion Approval Needed
Select your approver's name and submit to add item(s) to your cart
Approver Name
Please Select Approver Name
OR
Don't know your approval number? Call 800-437-1171
Enter opt 1 for the first three prompts, and have your System ID available.
If you add item(s) to cart and submit your order without
selecting an approver, GE will contact you before your order
can be confirmed for shipment.
Product Overview
Two mechanisms have been identified in triggering and maintaining atrial fibrillation. One is the enhanced automaticity in one or more depolarizing foci, and the other is re-entry involving one or more aberrant circuits. By the end of this program, the participant should be able to: 1. Understand the clinical practice guidelines of European Society of cardiology (ESC) for selecting best management strategies and determining risk-benefit ratio of a particular diagnostic or therapeutic means; 2. Apply the clinical practice guidelines of ESC for diagnosis, screening, and general management of Atrial Fibrillation (AF), as well as for prevention of stroke in AF; 3. Understand the Indian guidelines for selecting the right non-vitamin K oral coagulant (NOACs) for right patient for prevention of stroke in atrial fibrillation.
